Results 311 to 320 of about 19,192,428 (324)
Some of the next articles are maybe not open access.
Metabolic Determinants of Low HDL‐C Levels
Annals of the New York Academy of Sciences, 1993J L, Breslow, S, Eisenberg, E A, Brinton
openaire +2 more sources
THE ACUTE EFFECTS OF EXERCISE AT DIFFERENT INTENSITIES ON HDL-C AND HDL-C SUDFRACTIONS
Medicine & Science in Sports & Exercise, 1992P. M. Gordon +6 more
openaire +1 more source
Bad HDL-C Responders to Statins.
2006Lowering high levels of low-density lipoprotein cholesterol (LDL-C) is the primary aim in the prevention of cardiac events. However, low levels of high-density lipoprotein cholesterol (HDL-C) are also associated with an increased risk of ischemic heart disease. Lipid-lowering drugs are known to decrease LDL-C and to increase HDL-C slightly.
openaire +1 more source
1148 ACUTE CHANGES IN HDL-C, HDL-C SUBFRACTIONS AND LIPID ENZYMES FOLLOWING ACSM EXERCISE GUIDELINES
Medicine & Science in Sports & Exercise, 1993P. Visich, P. Gordon, F. Goss
openaire +1 more source
Emerging Predictors by Non-HDL-C/HDL-C Ratio and Novel Biomarkers for Coronary Slow Flow Phenomenon.
Acta Cardiologica SinicaThe coronary slow-flow (CSF) phenomenon is a condition characterized by delayed coronary opacification during diagnostic angiography without the presence of epicardial coronary artery disease. This mini-review explores various emerging predictors and biomarkers associated with CSF, aiming to address the potential diagnostic tools.
Tharmaraj, Vairaperumal +2 more
openaire +1 more source
Alterations of triglyceride, HDL-C and non-HDL-C levels in patients with acute coronary syndrome
Atherosclerosis, 2015P. Koncsos +6 more
openaire +1 more source